Private right to sue glyphosate exposure

Full Title:
No Immunity for Glyphosate Act

Summary#

This bill would stop federal money from being used to carry out Executive Order 14387 (about elemental phosphorus and glyphosate-based herbicides). It would also create a new federal right to sue manufacturers, distributors, sellers, and suppliers of elemental phosphorus and glyphosate-based herbicides for physical injury, illness, disease, or death caused by exposure. The bill removes certain legal immunities and bars some federal contractor and preemption defenses.

  • Main change: Bars use of federal funds to implement that Executive Order.
  • Main change: Allows any person (or their estate) who suffered physical harm from exposure to elemental phosphorus or a glyphosate-based herbicide to sue covered entities in U.S. district court.
  • Main change: Removes immunity that might otherwise apply under the Defense Production Act or other laws, and prevents covered entities from using compliance with federal orders or contracts as a defense.
  • Who is covered: Any person, company, contractor, or other entity that manufactures, distributes, formulates, supplies, or sells elemental phosphorus or glyphosate-based herbicides.
  • Retroactivity: The new private right of action applies to claims arising before, on, or after the bill’s enactment.
  • What is unclear: The bill does not define “glyphosate-based herbicide” in detail or specify legal standards (for example, how a plaintiff proves causation).

What it means for you#

  • People harmed by exposure (workers, residents, consumers): You may be able to bring a federal lawsuit for injuries, illness, or death you believe were caused by exposure to elemental phosphorus or a glyphosate-based herbicide. The courts may award medical costs, lost income, pain and suffering, punitive damages, injunctions, and lawyers’ fees.
  • Manufacturers, formulators, distributors, sellers, and suppliers: These entities would face potential new federal lawsuits without certain immunities. They could not use compliance with a federal Executive Order, Defense Production Act authorization, or related federal contracts as a blanket defense in these cases.
  • Federal contractors and subcontractors: Companies that supply these substances to the government may lose legal defenses tied to federal contracting or to the Defense Production Act.
  • Federal agencies and the Executive Branch: Agencies could not spend federal funds to implement, administer, or enforce Executive Order 14387. This could limit agency actions tied to that order.
  • Courts and legal system: Federal district courts must accept these cases regardless of the amount in controversy or the parties’ citizenship. This may increase federal litigation over these substances.
  • Insurers: Entities that insure manufacturers or sellers could face more claims, which could affect premiums or coverage terms.

Expenses#

No publicly available information.

  • This bill does not include a fiscal note in the provided material.
  • Possible likely effects (based on the bill text): increased litigation costs for businesses and insurers; potential administrative costs for federal agencies to change or stop work tied to the Executive Order; potential costs to the courts from added cases. These are not quantified in the provided material.

Proponents' View#

  • The bill appears intended to let people harmed by exposure to elemental phosphorus or glyphosate-based herbicides seek compensation in federal court.
  • Supporters may argue this removes special legal shields that would block accountability even when harm occurred.
  • The bill could be seen as preventing the Executive Order from being implemented using federal funds, so the Executive Order would not provide practical protection for companies.
  • A possible argument for the bill is that it preserves state and federal remedies and ensures injured people can obtain relief (including damages and injunctions).

Opponents' View#

  • One concern is that removing immunity and barring contractor defenses could increase litigation against companies that produce materials the government may need for emergencies. This could discourage production or raise costs.
  • The bill does not clearly define key terms (for example, what counts as a “glyphosate-based herbicide”), which may create legal uncertainty about what products and exposures are covered.
  • It is unclear how courts will handle causation standards and other proof issues for past exposures; this could lead to long, costly litigation.
  • The retroactive reach (covering claims before enactment) may raise questions about fairness and predictable legal obligations for companies.
  • The bill does not provide a fiscal estimate, so the budgetary effects on federal agencies, the judiciary, and state governments are not specified.